Subject attrition from randomized Schizophrenia trials is a significant problem and has been found in meta-analysis to be as high as 76% (Robinowitz et al., 2005). High drop-out rates introduce selection bias, decrease the validity of intent to treat (ITT) analysis, can lead to a decrease in statistical power, and can ultimately cloud signal detection. The problem of drop-out is typically not addressed until the statistical analysis stage of the study which can decrease the validity of the results, increasing the likelihood of failed and negative trials.
This week’s Industry Watch is covering better understanding of disease, from the relationship between COVID-19 and the gut - to the intersection of…
In the first week of November, Industry Watch brings you news of strategies to improve cancer screening via novel multi-cancer early detection (MCED)…
Shining a Spotlight on Down Syndrome Through Education, Advocacy, and Research
Learn the facts about Down syndrome, advocacy and research for this condition, and the neurodiversity movement.